Dermata Therapeutics Inc. Gains 46.84%

Dermata Therapeutics Inc. (DRMA:NASDAQ) soared at $2.32, representing a gain of 46.8%. On Fri, Sep 13, 2024, DRMA:NASDAQ touched a New 2-Week Intraday High of $1.74. The stock got featured on our News Catalysts scanner on Fri, Sep 06, 2024 at 04:34 AM in the 'MISCELLANEOUS' category. From Tue, Sep 03, 2024, the stock recorded 37.50% Up Days and 33.33% Green Days

The stock spiked on Wed, Jul 24, 2024 at $5 with a volume of 65M+, and its share price has been moving sideways in recent weeks.

About Dermata Therapeutics Inc. (DRMA:NASDAQ)

Dermata Therapeutics Inc is a clinical-stage biotechnology company. It is focused on the treatment of multiple medical and aesthetic skin conditions and diseases with high unmet needs.